标题
Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis
作者
关键词
-
出版物
CIRCULATION RESEARCH
Volume 128, Issue 10, Pages 1554-1575
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2021-05-14
DOI
10.1161/circresaha.121.318187
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy
- (2020) Dhruv S. Kazi et al. CIRCULATION
- Bendamustine With Dexamethasone in Relapsed/Refractory Systemic Light-Chain Amyloidosis: Results of a Phase II Study
- (2020) Suzanne Lentzsch et al. JOURNAL OF CLINICAL ONCOLOGY
- Tafamidis—A Pricey Therapy for a Not-So-Rare Condition
- (2020) Jerry H. Gurwitz et al. JAMA Cardiology
- Ixazomib-dexamethasone (Ixa-Dex) vs physician’s choice (PC) in relapsed/refractory (RR) primary systemic AL amyloidosis (AL) patients (pts) by prior proteasome inhibitor (PI) exposure in the phase III TOURMALINE-AL1 trial.
- (2020) Efstathios Kastritis et al. JOURNAL OF CLINICAL ONCOLOGY
- United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis
- (2020) Jan M. Griffin et al. CLINICAL TRANSPLANTATION
- Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation
- (2020) Christopher D. Barrett et al. JACC-Heart Failure
- Blinded potency comparison of transthyretin kinetic stabilisers by subunit exchange in human plasma
- (2020) Luke T. Nelson et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Comparing Outcomes for Infiltrative and Restrictive Cardiomyopathies under the New Heart Transplant Allocation System
- (2020) Jan M. Griffin et al. CLINICAL TRANSPLANTATION
- Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data
- (2020) Nicholas J. Viney et al. ESC Heart Failure
- Clinical Experience Using Doxycycline and Ursodeoxycholic Acid for the Treatment of Transthyretin Cardiac Amyloidosis
- (2019) Erin Karlstedt et al. JOURNAL OF CARDIAC FAILURE
- The proteostasis network and its decline in ageing
- (2019) Mark S. Hipp et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy
- (2019) Daniel P. Judge et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils
- (2019) Lorena Saelices et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Mechanism Of Action Of The Anti-CD38 Monoclonal Antibody Isatuximab In Multiple Myelmoa
- (2019) Laura Moreno et al. CLINICAL CANCER RESEARCH
- The pathology and changing epidemiology of Dialysis-related cardiac Beta-2 microglobulin amyloidosis
- (2019) Allison D. Morris et al. CARDIOVASCULAR PATHOLOGY
- Stabilization of amyloidogenic immunoglobulin light chains by small molecules
- (2019) Gareth J. Morgan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase 1 study of ALN-TTRsc02, a subcutaneously administered investigational RNAi therapeutic for the treatment of transthyretin-mediated amyloidosis
- (2019) David Adams et al. REVUE NEUROLOGIQUE
- Mechanistic Insights into the Early Events in the Aggregation of Immunoglobulin Light Chains
- (2019) Pinaki Misra et al. BIOCHEMISTRY
- Transthyretin Amyloid Cardiomyopathy
- (2019) Frederick L. Ruberg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy
- (2019) Richa Manwani et al. BRITISH JOURNAL OF HAEMATOLOGY
- Rationale and Design of a Phase 3 Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
- (2019) Rodney H Falk et al. BLOOD
- Preclinical Development of an Anti-CD38 Antibody-Drug Conjugate for Treatment of Hematological Malignancies
- (2019) Lingna Li et al. BLOOD
- A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib
- (2019) Richa Manwani et al. BLOOD
- Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
- (2019) Silpa Narayanan et al. DRUG RESISTANCE UPDATES
- Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis
- (2019) Graham Lohrmann et al. JOURNAL OF CARDIAC FAILURE
- RNA-Targeted Therapeutics
- (2018) Stanley T. Crooke et al. Cell Metabolism
- Improved outcomes after heart transplantation for cardiac amyloidosis in the modern era
- (2018) Arnt V. Kristen et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition
- (2018) Lorena Saelices et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
- (2018) Jonathan D. Finn et al. Cell Reports
- Immunoglobulin Light Chain Amyloidosis: 2018 Update on Diagnosis, Prognosis, and Treatment
- (2018) Morie A. Gertz AMERICAN JOURNAL OF HEMATOLOGY
- Glucocorticoids in multiple myeloma: past, present, and future
- (2018) Nicholas Burwick et al. ANNALS OF HEMATOLOGY
- Elotuzumab in Combination with Lenalidomide and Dexamethasone for Treatment Resistant Immunoglobulin Light Chain Amyloidosis with Multiple Myeloma
- (2018) Shumaila Muhammad Iqbal et al. Clinical Lymphoma Myeloma & Leukemia
- Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis
- (2018) Mark Miller et al. JOURNAL OF MEDICINAL CHEMISTRY
- Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio
- (2018) Eli Muchtar et al. LEUKEMIA
- Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
- (2018) Mathew S. Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Venetoclax for the treatment of multiple myeloma
- (2018) Iuliana Vaxman et al. Expert Review of Hematology
- Cellular uptake and trafficking of antisense oligonucleotides
- (2017) Stanley T Crooke et al. NATURE BIOTECHNOLOGY
- Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells
- (2017) Esther Imperlini et al. Scientific Reports
- Structure of Monomeric Transthyretin Carrying the Clinically Important T119M Mutation
- (2016) Jin Hae Kim et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Effect of melphalan 140 mg/m2vs 200 mg/m2on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experience
- (2016) Lakshmikanth Katragadda et al. CLINICAL TRANSPLANTATION
- Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
- (2016) Niels W. C. J. van de Donk et al. IMMUNOLOGICAL REVIEWS
- First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction
- (2016) Morie A. Gertz et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis
- (2016) H Landau et al. LEUKEMIA
- The activities of amyloids from a structural perspective
- (2016) Roland Riek et al. NATURE
- Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
- (2016) Ricardo Sant'Anna et al. Nature Communications
- Amyloidogenic and non-amyloidogenic transthyretin variants interact differently with human cardiomyocytes: insights into early events of non-fibrillar tissue damage
- (2015) Pallavi Manral et al. BIOSCIENCE REPORTS
- A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis
- (2015) G. Palladini et al. BLOOD
- Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases
- (2015) Brandon T Larsen et al. HISTOPATHOLOGY
- Uncovering the Mechanism of Aggregation of Human Transthyretin
- (2015) Lorena Saelices et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Translocation t(11;14) Is Associated With Adverse Outcome in Patients With Newly Diagnosed AL Amyloidosis When Treated With Bortezomib-Based Regimens
- (2015) Tilmann Bochtler et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component
- (2015) Duncan B. Richards et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
- (2015) Henk M. Lokhorst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
- (2015) Ole B Suhr et al. Orphanet Journal of Rare Diseases
- On the lag phase in amyloid fibril formation
- (2015) Paolo Arosio et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- Left Ventricular Structure and Function in Transthyretin-Related Versus Light-Chain Cardiac Amyloidosis
- (2014) Candida Cristina Quarta et al. CIRCULATION
- Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case–control study on 174 patients
- (2014) G Palladini et al. LEUKEMIA
- Age-Related Oxidative Modifications of Transthyretin Modulate Its Amyloidogenicity
- (2013) Lei Zhao et al. BIOCHEMISTRY
- Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC
- (2013) Shauna M. Collins et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach
- (2013) G. Palladini et al. HAEMATOLOGICA
- The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma
- (2013) C Touzeau et al. LEUKEMIA
- AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin
- (2013) S. C. Penchala et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amyloidosis in autoinflammatory syndromes
- (2012) Laura Obici et al. AUTOIMMUNITY REVIEWS
- A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis
- (2012) E. Kastritis et al. BLOOD
- Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis
- (2012) A. Dispenzieri et al. BLOOD
- Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial
- (2012) S. K. Kumar et al. BLOOD
- The Amyloid State of Proteins in Human Diseases
- (2012) David Eisenberg et al. CELL
- New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
- (2012) Giovanni Palladini et al. JOURNAL OF CLINICAL ONCOLOGY
- Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements
- (2012) Shaji Kumar et al. JOURNAL OF CLINICAL ONCOLOGY
- Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial
- (2012) T. Coelho et al. NEUROLOGY
- The repertoire of light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44
- (2011) V. Perfetti et al. BLOOD
- Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
- (2011) B. C. Potts et al. CURRENT CANCER DRUG TARGETS
- Radioimmunodetection of amyloid deposits in patients with AL amyloidosis
- (2010) J. S. Wall et al. BLOOD
- Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study
- (2010) P. Moreau et al. BLOOD
- Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement
- (2010) S. Dietrich et al. BLOOD
- Pressure-Volume Relationships in Patients With Transthyretin (ATTR) Cardiac Amyloidosis Secondary to V122I Mutations and Wild-Type Transthyretin
- (2010) Taslima Bhuiyan et al. Circulation-Heart Failure
- Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
- (2010) M. de Weers et al. JOURNAL OF IMMUNOLOGY
- Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
- (2010) Karl Bodin et al. NATURE
- Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38 MAPK pathway
- (2010) J. Shi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transthyretin: the servant of many masters
- (2009) Joel N. Buxbaum et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Matrix Metalloproteinases and Their Tissue Inhibitors in Cardiac Amyloidosis
- (2008) Andreia Biolo et al. Circulation-Heart Failure
- Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis
- (2008) E Ihse et al. JOURNAL OF PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now